Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 419

Results For "Health"

4771 News Found

Moderna says Covid-19 booster dose works against Omicron in lab study
News | December 20, 2021

Moderna says Covid-19 booster dose works against Omicron in lab study

Authorized booster increases Omicron neutralizing antibody levels approximately 37-fold


TeleRay and Radiobotics to provide radiology AI
News | December 20, 2021

TeleRay and Radiobotics to provide radiology AI

TeleRay partners with Radiobotics, adding Artificial Intelligence to their pre-existing integrated best-in-class medical image and patient information distribution platform


Boyd Corporation acquires MBK Tape Solutions
Packaging | December 17, 2021

Boyd Corporation acquires MBK Tape Solutions

Medical footprint expansion with deeper medical grade skin contact material science expertise


Telengana is now home to seven more medical devices companies
News | December 17, 2021

Telengana is now home to seven more medical devices companies

Since its launch, the medical devices park in Sultanpur has received overwhelming response with more than 50 companies lining up to set up their manufacturing or research and development units


Vakrangee partners with PharmEasy to deliver medicines to remote areas
Digitisation | December 16, 2021

Vakrangee partners with PharmEasy to deliver medicines to remote areas

Vakrangee through its Nextgen Kendras and BharatEasy Mobile Superaap will now be able to provide medicines & healthcare services in remote areas of the country


Serial entrepreneur Sanjeev Dahiwadkar joins RaphaCure Board
People | December 16, 2021

Serial entrepreneur Sanjeev Dahiwadkar joins RaphaCure Board

Dahiwadkar currently heads four technology companies- WipeOut Inc, Cognota Healthcare Technologies, IT Shastra India and Moringa Techsolv, which he has founded


Sun gets US FDA approval for generic amphotericin B injection
Drug Approval | December 16, 2021

Sun gets US FDA approval for generic amphotericin B injection

It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity


U.S. FDA approves Bristol Myers Squibb’s Orencia
Drug Approval | December 16, 2021

U.S. FDA approves Bristol Myers Squibb’s Orencia

Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant


USFDA grants Orphan Drug Designation to Zydus’ novel compound to treat malaria
Biotech | December 16, 2021

USFDA grants Orphan Drug Designation to Zydus’ novel compound to treat malaria

ZY19489 is a novel anti-malarial compound active against all current clinical strains of P. falciparum and P. vivax, including drug resistant strains